Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage

J Clin Gastroenterol. 1995 Apr;20(3):244-7. doi: 10.1097/00004836-199504000-00017.

Abstract

3,4-Methylenedioxymetamphetamine ("ecstasy") has previously been reported to cause an acute hepatitis that may progress to liver failure. We present the first recorded case of ecstasy-induced accelerated hepatic fibrosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / pathology
  • Female
  • Humans
  • Liver / drug effects
  • Liver / pathology
  • Liver Cirrhosis / chemically induced*
  • Liver Cirrhosis / pathology
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*

Substances

  • N-Methyl-3,4-methylenedioxyamphetamine